Make your money go further for just 25p per day

PREMIUM
AIM IHT

Why I’m buying: CVS Group

Cat and dog sitting together

The UK's largest provider of veterinary services has been a mainstay of Fundamental Asset Management's AIM portfolio for many years. But what made them keep the faith when the company disappointed the market with a series of profit warnings and what does the future hold?


Shareholders were rightly losing patience with veterinary services business CVS Group (LON: CVSG) in January following a series of disappointing trading updates. The dynamics of the UK veterinary market have changed significantly over past few years and a shortage of newly qualified vets, combined with the rapid consolidation of the sector, was making life hard for CVS, the UK’s largest consolidator.

The group was also ploughing on with its manic acquisition spree, moving into The Netherlands and…

Continue reading our content…

Gain access to all our excellent content for just £90 per year, that’s just 25p per day for financial freedom.
  • Unlimited access to our market-beating portfolios
  • In-depth coverage of many of the world’s great companies
  • Unique insights from our top research team
Register FREE for access to limited content.
  • Company and markets insights
  • Sponsored content
  • Podcasts

Previous article Next article

DON'T MISS OUT!

Get top investment ideas to help safeguard and grow your wealth.

Invaluable insight from the exciting world of smaller companies.

REGISTER FREE

DON'T MISS OUT ON OUR PREMIUM CONTENT

Become a champion investor for just £90 a year. Benefit from our high performing portfolios:

START FREE TRIAL

More on CVS Group

Licensing appeal | Veterinary relief | EV growth

17/10/2025 · Company Insights

A modestly valued company covered here has evident brand and licensing appeal, but it’s manufacturing operations…


Gold winner | Fishing delight | Veterinary vexation

08/10/2025 · Company Insights

The latest positive trading update from a beneficiary of the soaring gold price strangely saw the…


More Company Insights

Licensing appeal | Veterinary relief | EV growth

Bonkers Bargain: shares climb on positive update

16/10/2025 · IXICO

Sign-up to our free email updates

SIGN UP